

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 5.78081862 |
| 2 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 5.76580914 |
| 3 | locomotory exploration behavior (GO:0035641) | 5.35579130 |
| 4 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 5.32727074 |
| 5 | vocalization behavior (GO:0071625) | 5.32315341 |
| 6 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 5.03349807 |
| 7 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 5.00250296 |
| 8 | protein localization to synapse (GO:0035418) | 4.87888806 |
| 9 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 4.81774033 |
| 10 | glutamate receptor signaling pathway (GO:0007215) | 4.77504741 |
| 11 | regulation of glutamate receptor signaling pathway (GO:1900449) | 4.77367883 |
| 12 | synaptic vesicle maturation (GO:0016188) | 4.76914512 |
| 13 | regulation of synapse structural plasticity (GO:0051823) | 4.65866435 |
| 14 | synaptic vesicle exocytosis (GO:0016079) | 4.62105732 |
| 15 | synaptic transmission, glutamatergic (GO:0035249) | 4.57476828 |
| 16 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 4.53351267 |
| 17 | regulation of neuronal synaptic plasticity (GO:0048168) | 4.51883666 |
| 18 | neuron-neuron synaptic transmission (GO:0007270) | 4.44352937 |
| 19 | neuronal action potential propagation (GO:0019227) | 4.36556945 |
| 20 | exploration behavior (GO:0035640) | 4.36003633 |
| 21 | cilium or flagellum-dependent cell motility (GO:0001539) | 4.35689245 |
| 22 | regulation of skeletal muscle contraction (GO:0014819) | 4.28144902 |
| 23 | neuron cell-cell adhesion (GO:0007158) | 4.27695736 |
| 24 | neurotransmitter-gated ion channel clustering (GO:0072578) | 4.24474556 |
| 25 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.18152825 |
| 26 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 4.17678440 |
| 27 | prepulse inhibition (GO:0060134) | 4.11622130 |
| 28 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 4.11511762 |
| 29 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 4.11446924 |
| 30 | dendritic spine morphogenesis (GO:0060997) | 4.09154003 |
| 31 | long-term memory (GO:0007616) | 4.08737122 |
| 32 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 4.06848286 |
| 33 | regulation of dendritic spine morphogenesis (GO:0061001) | 4.02639639 |
| 34 | striatum development (GO:0021756) | 3.98965641 |
| 35 | axonemal dynein complex assembly (GO:0070286) | 3.94393857 |
| 36 | synaptic transmission, dopaminergic (GO:0001963) | 3.93421242 |
| 37 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 3.93297493 |
| 38 | regulation of postsynaptic membrane potential (GO:0060078) | 3.92169142 |
| 39 | transmission of nerve impulse (GO:0019226) | 3.91078654 |
| 40 | neurotransmitter secretion (GO:0007269) | 3.86247109 |
| 41 | cilium movement (GO:0003341) | 3.83955495 |
| 42 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 3.81887382 |
| 43 | positive regulation of membrane potential (GO:0045838) | 3.81871057 |
| 44 | regulation of synaptic vesicle transport (GO:1902803) | 3.81220848 |
| 45 | glutamate secretion (GO:0014047) | 3.80374500 |
| 46 | positive regulation of synapse maturation (GO:0090129) | 3.78720183 |
| 47 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 3.78627427 |
| 48 | behavioral defense response (GO:0002209) | 3.76983975 |
| 49 | behavioral fear response (GO:0001662) | 3.76983975 |
| 50 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 3.76766685 |
| 51 | neuron recognition (GO:0008038) | 3.76673227 |
| 52 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.76453047 |
| 53 | cellular potassium ion homeostasis (GO:0030007) | 3.73824312 |
| 54 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 3.70650412 |
| 55 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 3.69815155 |
| 56 | regulation of synaptic plasticity (GO:0048167) | 3.68788220 |
| 57 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.68434338 |
| 58 | auditory behavior (GO:0031223) | 3.66654161 |
| 59 | axonal fasciculation (GO:0007413) | 3.66126196 |
| 60 | neuronal ion channel clustering (GO:0045161) | 3.63663896 |
| 61 | long-term synaptic potentiation (GO:0060291) | 3.60831234 |
| 62 | epithelial cilium movement (GO:0003351) | 3.58659532 |
| 63 | layer formation in cerebral cortex (GO:0021819) | 3.57947258 |
| 64 | positive regulation of neurotransmitter transport (GO:0051590) | 3.55872485 |
| 65 | neuromuscular process controlling balance (GO:0050885) | 3.52824423 |
| 66 | positive regulation of neurotransmitter secretion (GO:0001956) | 3.51832891 |
| 67 | regulation of relaxation of muscle (GO:1901077) | 3.51814250 |
| 68 | response to histamine (GO:0034776) | 3.51184808 |
| 69 | behavioral response to nicotine (GO:0035095) | 3.49973742 |
| 70 | behavioral response to cocaine (GO:0048148) | 3.49401520 |
| 71 | response to auditory stimulus (GO:0010996) | 3.48491923 |
| 72 | gamma-aminobutyric acid transport (GO:0015812) | 3.48069667 |
| 73 | membrane depolarization during action potential (GO:0086010) | 3.47376584 |
| 74 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 3.47354508 |
| 75 | actin-myosin filament sliding (GO:0033275) | 3.46740613 |
| 76 | muscle filament sliding (GO:0030049) | 3.46740613 |
| 77 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 3.46522483 |
| 78 | membrane hyperpolarization (GO:0060081) | 3.44013994 |
| 79 | neuronal action potential (GO:0019228) | 3.42825393 |
| 80 | fear response (GO:0042596) | 3.40601319 |
| 81 | presynaptic membrane assembly (GO:0097105) | 3.39667823 |
| 82 | axoneme assembly (GO:0035082) | 3.38294332 |
| 83 | response to amphetamine (GO:0001975) | 3.37995295 |
| 84 | positive regulation of phosphoprotein phosphatase activity (GO:0032516) | 3.37990132 |
| 85 | membrane depolarization (GO:0051899) | 3.37010595 |
| 86 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 3.36254104 |
| 87 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 3.36225985 |
| 88 | innervation (GO:0060384) | 3.34204373 |
| 89 | learning (GO:0007612) | 3.32499739 |
| 90 | adenylate cyclase-activating dopamine receptor signaling pathway (GO:0007191) | 3.31841265 |
| 91 | neuromuscular synaptic transmission (GO:0007274) | 3.28871702 |
| 92 | regulation of glutamate secretion (GO:0014048) | 3.28644479 |
| 93 | regulation of dendritic spine development (GO:0060998) | 3.27532637 |
| 94 | synaptic vesicle endocytosis (GO:0048488) | 3.25769225 |
| 95 | positive regulation of dendritic spine development (GO:0060999) | 3.23952315 |
| 96 | regulation of female receptivity (GO:0045924) | 3.23747300 |
| 97 | dopamine receptor signaling pathway (GO:0007212) | 3.23317766 |
| 98 | dendritic spine organization (GO:0097061) | 3.21845420 |
| 99 | regulation of vesicle fusion (GO:0031338) | 3.20841586 |
| 100 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.20068518 |
| 101 | neurotransmitter transport (GO:0006836) | 3.19418968 |
| 102 | regulation of cell communication by electrical coupling (GO:0010649) | 3.18023251 |
| 103 | sodium ion export (GO:0071436) | 3.18012334 |
| 104 | protein polyglutamylation (GO:0018095) | 3.17114229 |
| 105 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 3.12851351 |
| 106 | presynaptic membrane organization (GO:0097090) | 3.11548218 |
| 107 | skeletal muscle contraction (GO:0003009) | 3.10235263 |
| 108 | visual learning (GO:0008542) | 3.07291283 |
| 109 | long term synaptic depression (GO:0060292) | 3.07059135 |
| 110 | cell communication by electrical coupling (GO:0010644) | 3.05122620 |
| 111 | postsynaptic membrane organization (GO:0001941) | 3.04039706 |
| 112 | activation of protein kinase A activity (GO:0034199) | 3.03321097 |
| 113 | regulation of neurotransmitter secretion (GO:0046928) | 3.03149416 |
| 114 | positive regulation of synaptic transmission (GO:0050806) | 3.02942495 |
| 115 | proline transport (GO:0015824) | 3.02495316 |
| 116 | cAMP catabolic process (GO:0006198) | 3.01771705 |
| 117 | neuromuscular process controlling posture (GO:0050884) | 3.01542040 |
| 118 | synapse assembly (GO:0007416) | 3.01320605 |
| 119 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.00510250 |
| 120 | mating behavior (GO:0007617) | 2.99263086 |
| 121 | response to pheromone (GO:0019236) | 2.98794331 |
| 122 | regulation of neurotransmitter levels (GO:0001505) | 2.97885442 |
| 123 | neuromuscular process (GO:0050905) | 2.96870946 |
| 124 | axon ensheathment in central nervous system (GO:0032291) | 2.91334984 |
| 125 | central nervous system myelination (GO:0022010) | 2.91334984 |
| 126 | * negative regulation of cytosolic calcium ion concentration (GO:0051481) | 2.90476777 |
| 127 | motile cilium assembly (GO:0044458) | 2.89487753 |
| 128 | action potential (GO:0001508) | 2.84402094 |
| 129 | serotonin metabolic process (GO:0042428) | 2.83642651 |
| 130 | primary amino compound metabolic process (GO:1901160) | 2.82778662 |
| 131 | actin-mediated cell contraction (GO:0070252) | 2.81446757 |
| 132 | C4-dicarboxylate transport (GO:0015740) | 2.80825214 |
| 133 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 2.75286030 |
| 134 | regulation of membrane repolarization (GO:0060306) | 2.75043793 |
| 135 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 2.74974089 |
| 136 | regulation of neurotransmitter uptake (GO:0051580) | 2.73855674 |
| 137 | detection of mechanical stimulus involved in sensory perception of sound (GO:0050910) | 2.72250970 |
| 138 | startle response (GO:0001964) | 2.66485735 |
| 139 | retinal cone cell development (GO:0046549) | 2.65870608 |
| 140 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 2.65737612 |
| 141 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 2.65423160 |
| 142 | detection of light stimulus involved in visual perception (GO:0050908) | 2.65412460 |
| 143 | detection of light stimulus involved in sensory perception (GO:0050962) | 2.65412460 |
| 144 | reflex (GO:0060004) | 2.64159542 |
| 145 | cornea development in camera-type eye (GO:0061303) | 2.61521679 |
| 146 | interkinetic nuclear migration (GO:0022027) | 2.59471178 |
| 147 | regulation of cilium movement (GO:0003352) | 2.56646941 |
| 148 | one-carbon compound transport (GO:0019755) | 2.56228198 |
| 149 | regulation of sarcomere organization (GO:0060297) | 2.55301302 |
| 150 | positive regulation of sodium ion transmembrane transport (GO:1902307) | 2.54197895 |
| 151 | myotube cell development (GO:0014904) | 2.53856215 |
| 152 | left/right axis specification (GO:0070986) | 2.53846547 |
| 153 | myofibril assembly (GO:0030239) | 2.52906247 |
| 154 | regulation of action potential (GO:0098900) | 2.52755766 |
| 155 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 2.52566864 |
| 156 | * striated muscle contraction (GO:0006941) | 2.49169651 |
| 157 | cilium organization (GO:0044782) | 2.49087503 |
| 158 | response to inactivity (GO:0014854) | 2.48712590 |
| 159 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 2.47385476 |
| 160 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 2.45747084 |
| 161 | somite development (GO:0061053) | 2.44089549 |
| 162 | neural tube formation (GO:0001841) | 2.42548299 |
| 163 | cilium assembly (GO:0042384) | 2.42225690 |
| 164 | otic vesicle formation (GO:0030916) | 2.40867216 |
| 165 | positive regulation of meiosis (GO:0045836) | 2.40562300 |
| 166 | regulation of sodium ion transmembrane transporter activity (GO:2000649) | 2.40524299 |
| 167 | skeletal muscle fiber development (GO:0048741) | 2.39999941 |
| 168 | behavioral response to ethanol (GO:0048149) | 2.39873921 |
| 169 | calcium ion import (GO:0070509) | 2.39801852 |
| 170 | microtubule bundle formation (GO:0001578) | 2.39481956 |
| 171 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 2.38405362 |
| 172 | regulation of synapse maturation (GO:0090128) | 2.37698553 |
| 173 | potassium ion transmembrane transport (GO:0071805) | 2.36826118 |
| 174 | cellular potassium ion transport (GO:0071804) | 2.36826118 |
| 175 | regulation of sodium ion transmembrane transport (GO:1902305) | 2.36668826 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 5.71723982 |
| 2 | * GBX2_23144817_ChIP-Seq_PC3_Human | 3.89495051 |
| 3 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 3.11315432 |
| 4 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 3.09109101 |
| 5 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 3.09003125 |
| 6 | * RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.79055425 |
| 7 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.68696026 |
| 8 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.68696026 |
| 9 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.66840552 |
| 10 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.66127478 |
| 11 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.65227689 |
| 12 | * REST_21632747_ChIP-Seq_MESCs_Mouse | 2.60189328 |
| 13 | VDR_22108803_ChIP-Seq_LS180_Human | 2.57651258 |
| 14 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.53175595 |
| 15 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.49204507 |
| 16 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.45923121 |
| 17 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.44981280 |
| 18 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.41786074 |
| 19 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.31076420 |
| 20 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 2.30209366 |
| 21 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.22268212 |
| 22 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.20262266 |
| 23 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.19703152 |
| 24 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.11797199 |
| 25 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.05565025 |
| 26 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 2.01583331 |
| 27 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 2.00476583 |
| 28 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.87611888 |
| 29 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.87510278 |
| 30 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.85513591 |
| 31 | * CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.81791130 |
| 32 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.78438068 |
| 33 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.77924207 |
| 34 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.75496757 |
| 35 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.72426113 |
| 36 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.68058155 |
| 37 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.62736336 |
| 38 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.61542850 |
| 39 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.60133375 |
| 40 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.54625985 |
| 41 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.53476718 |
| 42 | * PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.52449955 |
| 43 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.51110984 |
| 44 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.48541109 |
| 45 | * P300_19829295_ChIP-Seq_ESCs_Human | 1.44834657 |
| 46 | * MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.43090504 |
| 47 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.41820799 |
| 48 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.41820799 |
| 49 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.40347033 |
| 50 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.37492474 |
| 51 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.36452553 |
| 52 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.34614534 |
| 53 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.33929832 |
| 54 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.33128191 |
| 55 | * STAT3_23295773_ChIP-Seq_U87_Human | 1.32751571 |
| 56 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.30869909 |
| 57 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.29394443 |
| 58 | * SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.28998732 |
| 59 | AR_25329375_ChIP-Seq_VCAP_Human | 1.27769839 |
| 60 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.27336750 |
| 61 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.27151618 |
| 62 | EWS_26573619_Chip-Seq_HEK293_Human | 1.26603189 |
| 63 | * AR_19668381_ChIP-Seq_PC3_Human | 1.24717451 |
| 64 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.23399345 |
| 65 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.21854111 |
| 66 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.21810554 |
| 67 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.20117846 |
| 68 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.19479538 |
| 69 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.18982603 |
| 70 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.18976965 |
| 71 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.18958393 |
| 72 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.18631091 |
| 73 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.18591408 |
| 74 | TP53_16413492_ChIP-PET_HCT116_Human | 1.17894689 |
| 75 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.17273200 |
| 76 | * TCF4_23295773_ChIP-Seq_U87_Human | 1.16004523 |
| 77 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.15821274 |
| 78 | * TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.15765595 |
| 79 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.15459437 |
| 80 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.15283318 |
| 81 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.13724612 |
| 82 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.11910636 |
| 83 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.11910636 |
| 84 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.11047786 |
| 85 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.10960987 |
| 86 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.10657094 |
| 87 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.10523270 |
| 88 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.09877496 |
| 89 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.09770224 |
| 90 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.09765775 |
| 91 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.09498502 |
| 92 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.09427641 |
| 93 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.09238199 |
| 94 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.08968746 |
| 95 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.08551330 |
| 96 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.08254603 |
| 97 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.08107084 |
| 98 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.07957445 |
| 99 | * P53_22387025_ChIP-Seq_ESCs_Mouse | 1.07895833 |
| 100 | * EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.06902584 |
| 101 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.06409365 |
| 102 | * SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.05680330 |
| 103 | * MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.05314782 |
| 104 | FUS_26573619_Chip-Seq_HEK293_Human | 1.05118796 |
| 105 | * AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.04895840 |
| 106 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.03760486 |
| 107 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.03451494 |
| 108 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.03319407 |
| 109 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.02875514 |
| 110 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.02423226 |
| 111 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.02213353 |
| 112 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.02071261 |
| 113 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.01965755 |
| 114 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.01778524 |
| 115 | * E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.01707914 |
| 116 | * BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.00865825 |
| 117 | * TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.99443986 |
| 118 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.96680478 |
| 119 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.95920197 |
| 120 | * SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.93973653 |
| 121 | * NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.92653883 |
| 122 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 0.92155886 |
| 123 | * NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.91711980 |
| 124 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.91703973 |
| 125 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.91703973 |
| 126 | * SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.89054608 |
| 127 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.88509099 |
| 128 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.88311526 |
| 129 | KDM2B_26808549_Chip-Seq_K562_Human | 0.87921461 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 6.62686411 |
| 2 | MP0003880_abnormal_central_pattern | 5.28111670 |
| 3 | MP0002822_catalepsy | 4.92146522 |
| 4 | * MP0003635_abnormal_synaptic_transmissio | 4.16029608 |
| 5 | MP0003646_muscle_fatigue | 3.85712684 |
| 6 | MP0009745_abnormal_behavioral_response | 3.64074664 |
| 7 | MP0004270_analgesia | 3.52720287 |
| 8 | * MP0002063_abnormal_learning/memory/cond | 3.43801008 |
| 9 | MP0002064_seizures | 3.09789427 |
| 10 | MP0001968_abnormal_touch/_nociception | 2.82634306 |
| 11 | MP0009046_muscle_twitch | 2.81556168 |
| 12 | * MP0002572_abnormal_emotion/affect_behav | 2.79271419 |
| 13 | MP0001486_abnormal_startle_reflex | 2.66262885 |
| 14 | MP0002272_abnormal_nervous_system | 2.62613322 |
| 15 | MP0005423_abnormal_somatic_nervous | 2.55590594 |
| 16 | MP0001501_abnormal_sleep_pattern | 2.42398245 |
| 17 | MP0000749_muscle_degeneration | 2.41477659 |
| 18 | MP0002734_abnormal_mechanical_nocicepti | 2.30888431 |
| 19 | MP0002736_abnormal_nociception_after | 2.16827510 |
| 20 | MP0001529_abnormal_vocalization | 2.13341452 |
| 21 | MP0002735_abnormal_chemical_nociception | 2.01400092 |
| 22 | MP0001440_abnormal_grooming_behavior | 1.93497900 |
| 23 | MP0002638_abnormal_pupillary_reflex | 1.87965648 |
| 24 | MP0002067_abnormal_sensory_capabilities | 1.85961414 |
| 25 | MP0005646_abnormal_pituitary_gland | 1.85500072 |
| 26 | MP0002909_abnormal_adrenal_gland | 1.84044951 |
| 27 | MP0001188_hyperpigmentation | 1.81683417 |
| 28 | MP0004130_abnormal_muscle_cell | 1.78126354 |
| 29 | MP0001970_abnormal_pain_threshold | 1.75280213 |
| 30 | MP0004924_abnormal_behavior | 1.72280736 |
| 31 | MP0005386_behavior/neurological_phenoty | 1.72280736 |
| 32 | MP0002733_abnormal_thermal_nociception | 1.71446407 |
| 33 | MP0002184_abnormal_innervation | 1.70278764 |
| 34 | MP0002557_abnormal_social/conspecific_i | 1.69365092 |
| 35 | MP0000778_abnormal_nervous_system | 1.68391143 |
| 36 | MP0008569_lethality_at_weaning | 1.67779669 |
| 37 | MP0001984_abnormal_olfaction | 1.64307736 |
| 38 | MP0004036_abnormal_muscle_relaxation | 1.64253099 |
| 39 | MP0004811_abnormal_neuron_physiology | 1.56372732 |
| 40 | MP0004043_abnormal_pH_regulation | 1.55979439 |
| 41 | MP0003879_abnormal_hair_cell | 1.50862018 |
| 42 | MP0009780_abnormal_chondrocyte_physiolo | 1.50045405 |
| 43 | MP0003329_amyloid_beta_deposits | 1.45463374 |
| 44 | MP0000955_abnormal_spinal_cord | 1.44256867 |
| 45 | MP0003787_abnormal_imprinting | 1.43783274 |
| 46 | MP0005253_abnormal_eye_physiology | 1.39607283 |
| 47 | MP0005409_darkened_coat_color | 1.39054117 |
| 48 | MP0004885_abnormal_endolymph | 1.36162954 |
| 49 | MP0002882_abnormal_neuron_morphology | 1.34111152 |
| 50 | * MP0002066_abnormal_motor_capabilities/c | 1.33744345 |
| 51 | MP0008877_abnormal_DNA_methylation | 1.30121490 |
| 52 | MP0002106_abnormal_muscle_physiology | 1.29865662 |
| 53 | * MP0005620_abnormal_muscle_contractility | 1.29044992 |
| 54 | MP0004147_increased_porphyrin_level | 1.28557293 |
| 55 | MP0006276_abnormal_autonomic_nervous | 1.28387250 |
| 56 | MP0004858_abnormal_nervous_system | 1.26570281 |
| 57 | MP0001502_abnormal_circadian_rhythm | 1.24482418 |
| 58 | MP0003633_abnormal_nervous_system | 1.24219455 |
| 59 | MP0004133_heterotaxia | 1.22199335 |
| 60 | MP0003283_abnormal_digestive_organ | 1.21414602 |
| 61 | MP0004142_abnormal_muscle_tone | 1.20845345 |
| 62 | MP0005551_abnormal_eye_electrophysiolog | 1.20663304 |
| 63 | MP0004145_abnormal_muscle_electrophysio | 1.19362454 |
| 64 | MP0005369_muscle_phenotype | 1.18856859 |
| 65 | MP0002876_abnormal_thyroid_physiology | 1.17611825 |
| 66 | MP0004084_abnormal_cardiac_muscle | 1.16299090 |
| 67 | MP0002653_abnormal_ependyma_morphology | 1.15298568 |
| 68 | MP0000569_abnormal_digit_pigmentation | 1.15139158 |
| 69 | MP0001986_abnormal_taste_sensitivity | 1.12681821 |
| 70 | MP0001905_abnormal_dopamine_level | 1.09407132 |
| 71 | MP0005645_abnormal_hypothalamus_physiol | 1.08793357 |
| 72 | MP0002332_abnormal_exercise_endurance | 1.06934036 |
| 73 | MP0000751_myopathy | 1.04866460 |
| 74 | MP0002152_abnormal_brain_morphology | 1.02365165 |
| 75 | MP0008872_abnormal_physiological_respon | 1.00961906 |
| 76 | MP0003631_nervous_system_phenotype | 1.00117908 |
| 77 | MP0008874_decreased_physiological_sensi | 0.99422395 |
| 78 | MP0001177_atelectasis | 0.97664747 |
| 79 | MP0004085_abnormal_heartbeat | 0.97097334 |
| 80 | MP0008875_abnormal_xenobiotic_pharmacok | 0.94924783 |
| 81 | MP0002069_abnormal_eating/drinking_beha | 0.94290649 |
| 82 | MP0003122_maternal_imprinting | 0.93920100 |
| 83 | MP0002160_abnormal_reproductive_system | 0.93550927 |
| 84 | MP0004742_abnormal_vestibular_system | 0.92026542 |
| 85 | MP0003195_calcinosis | 0.91003586 |
| 86 | MP0002127_abnormal_cardiovascular_syste | 0.90918464 |
| 87 | MP0002229_neurodegeneration | 0.90902025 |
| 88 | MP0003137_abnormal_impulse_conducting | 0.90443422 |
| 89 | MP0000383_abnormal_hair_follicle | 0.90295688 |
| 90 | MP0000372_irregular_coat_pigmentation | 0.89320000 |
| 91 | MP0010386_abnormal_urinary_bladder | 0.89104183 |
| 92 | MP0003075_altered_response_to | 0.88885461 |
| 93 | MP0003136_yellow_coat_color | 0.88364015 |
| 94 | MP0000631_abnormal_neuroendocrine_gland | 0.87623583 |
| 95 | MP0002090_abnormal_vision | 0.85666316 |
| 96 | MP0002108_abnormal_muscle_morphology | 0.84991205 |
| 97 | MP0004215_abnormal_myocardial_fiber | 0.84930515 |
| 98 | MP0004087_abnormal_muscle_fiber | 0.84362296 |
| 99 | MP0000747_muscle_weakness | 0.83659365 |
| 100 | MP0002269_muscular_atrophy | 0.83191474 |
| 101 | MP0005499_abnormal_olfactory_system | 0.81864528 |
| 102 | MP0005394_taste/olfaction_phenotype | 0.81864528 |
| 103 | MP0002234_abnormal_pharynx_morphology | 0.80850772 |
| 104 | MP0006292_abnormal_olfactory_placode | 0.80709648 |
| 105 | MP0000759_abnormal_skeletal_muscle | 0.79055873 |
| 106 | MP0005535_abnormal_body_temperature | 0.77237468 |
| 107 | MP0004510_myositis | 0.76876223 |
| 108 | MP0008961_abnormal_basal_metabolism | 0.76227144 |
| 109 | MP0002837_dystrophic_cardiac_calcinosis | 0.75073483 |
| 110 | MP0002752_abnormal_somatic_nervous | 0.74598256 |
| 111 | MP0000230_abnormal_systemic_arterial | 0.74220908 |
| 112 | MP0008775_abnormal_heart_ventricle | 0.73701861 |
| 113 | MP0004233_abnormal_muscle_weight | 0.73516724 |
| 114 | MP0003634_abnormal_glial_cell | 0.73336106 |
| 115 | MP0001963_abnormal_hearing_physiology | 0.73331385 |
| 116 | MP0003011_delayed_dark_adaptation | 0.71583524 |
| 117 | MP0001485_abnormal_pinna_reflex | 0.69659977 |
| 118 | MP0000920_abnormal_myelination | 0.69291328 |
| 119 | MP0003690_abnormal_glial_cell | 0.66340910 |
| 120 | MP0005167_abnormal_blood-brain_barrier | 0.65565423 |
| 121 | MP0003045_fibrosis | 0.61330650 |
| 122 | MP0003632_abnormal_nervous_system | 0.61304567 |
| 123 | MP0004484_altered_response_of | 0.60312703 |
| 124 | MP0000013_abnormal_adipose_tissue | 0.59014958 |
| 125 | MP0001664_abnormal_digestion | 0.57781214 |
| 126 | MP0000604_amyloidosis | 0.54746134 |
| 127 | MP0002102_abnormal_ear_morphology | 0.53929243 |
| 128 | MP0001299_abnormal_eye_distance/ | 0.53501491 |
| 129 | MP0006072_abnormal_retinal_apoptosis | 0.52942188 |
| 130 | MP0001943_abnormal_respiration | 0.52229290 |
| 131 | MP0000026_abnormal_inner_ear | 0.51807420 |
| 132 | MP0003861_abnormal_nervous_system | 0.49681006 |
| 133 | MP0010769_abnormal_survival | 0.48813248 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 8.31812055 |
| 2 | Myokymia (HP:0002411) | 7.48367683 |
| 3 | Focal seizures (HP:0007359) | 6.13254391 |
| 4 | Muscle fiber inclusion bodies (HP:0100299) | 5.00307803 |
| 5 | Nemaline bodies (HP:0003798) | 4.86700902 |
| 6 | Epileptic encephalopathy (HP:0200134) | 4.83381015 |
| 7 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 4.80911584 |
| 8 | Visual hallucinations (HP:0002367) | 4.68883673 |
| 9 | Febrile seizures (HP:0002373) | 4.68194272 |
| 10 | Absence seizures (HP:0002121) | 4.28897343 |
| 11 | Action tremor (HP:0002345) | 4.01624881 |
| 12 | Progressive cerebellar ataxia (HP:0002073) | 4.00968121 |
| 13 | Atonic seizures (HP:0010819) | 3.93887528 |
| 14 | Dialeptic seizures (HP:0011146) | 3.92771328 |
| 15 | Generalized tonic-clonic seizures (HP:0002069) | 3.91268575 |
| 16 | Broad-based gait (HP:0002136) | 3.80999745 |
| 17 | Muscle hypertrophy of the lower extremities (HP:0008968) | 3.80823471 |
| 18 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 3.79901474 |
| 19 | Distal arthrogryposis (HP:0005684) | 3.73177305 |
| 20 | Absent/shortened dynein arms (HP:0200106) | 3.65114398 |
| 21 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 3.65114398 |
| 22 | Poor eye contact (HP:0000817) | 3.59042306 |
| 23 | Calf muscle hypertrophy (HP:0008981) | 3.58545396 |
| 24 | Abnormal ciliary motility (HP:0012262) | 3.54684807 |
| 25 | Pancreatic fibrosis (HP:0100732) | 3.53626413 |
| 26 | True hermaphroditism (HP:0010459) | 3.50267791 |
| 27 | Abnormal respiratory motile cilium morphology (HP:0005938) | 3.47360511 |
| 28 | Abnormal respiratory epithelium morphology (HP:0012253) | 3.47360511 |
| 29 | Abnormal respiratory motile cilium physiology (HP:0012261) | 3.45088628 |
| 30 | Pancreatic cysts (HP:0001737) | 3.44958629 |
| 31 | Impaired vibration sensation in the lower limbs (HP:0002166) | 3.40410683 |
| 32 | Dysdiadochokinesis (HP:0002075) | 3.35571154 |
| 33 | Gaze-evoked nystagmus (HP:0000640) | 3.34088930 |
| 34 | Hyperventilation (HP:0002883) | 3.31951417 |
| 35 | Abnormal social behavior (HP:0012433) | 3.28732503 |
| 36 | Impaired social interactions (HP:0000735) | 3.28732503 |
| 37 | Type 1 muscle fiber predominance (HP:0003803) | 3.27960580 |
| 38 | Nephronophthisis (HP:0000090) | 3.27416513 |
| 39 | Dysmetria (HP:0001310) | 3.23091323 |
| 40 | Supranuclear gaze palsy (HP:0000605) | 3.22593517 |
| 41 | Anxiety (HP:0000739) | 3.21613926 |
| 42 | Depression (HP:0000716) | 3.19894333 |
| 43 | Exercise-induced myalgia (HP:0003738) | 3.18083741 |
| 44 | Molar tooth sign on MRI (HP:0002419) | 3.13272638 |
| 45 | Abnormality of midbrain morphology (HP:0002418) | 3.13272638 |
| 46 | Congenital stationary night blindness (HP:0007642) | 3.11224830 |
| 47 | Truncal ataxia (HP:0002078) | 3.08251001 |
| 48 | Rhinitis (HP:0012384) | 3.01667775 |
| 49 | Ankle clonus (HP:0011448) | 3.00302775 |
| 50 | Torticollis (HP:0000473) | 2.98439794 |
| 51 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.98138467 |
| 52 | Scanning speech (HP:0002168) | 2.89504922 |
| 53 | Exercise-induced muscle cramps (HP:0003710) | 2.89421394 |
| 54 | Excessive salivation (HP:0003781) | 2.83679681 |
| 55 | Drooling (HP:0002307) | 2.83679681 |
| 56 | Amblyopia (HP:0000646) | 2.76437729 |
| 57 | Postural instability (HP:0002172) | 2.75507886 |
| 58 | Abnormality of the renal medulla (HP:0100957) | 2.74330627 |
| 59 | Abnormality of the calf musculature (HP:0001430) | 2.72600679 |
| 60 | Hemiparesis (HP:0001269) | 2.72062432 |
| 61 | Stereotypic behavior (HP:0000733) | 2.68940823 |
| 62 | Impaired smooth pursuit (HP:0007772) | 2.66350679 |
| 63 | Absent phalangeal crease (HP:0006109) | 2.62342113 |
| 64 | Annular pancreas (HP:0001734) | 2.62098840 |
| 65 | Cystic liver disease (HP:0006706) | 2.59791059 |
| 66 | Genetic anticipation (HP:0003743) | 2.59499229 |
| 67 | Cerebral inclusion bodies (HP:0100314) | 2.58904248 |
| 68 | Mutism (HP:0002300) | 2.58772451 |
| 69 | Focal dystonia (HP:0004373) | 2.57725812 |
| 70 | Neurofibrillary tangles (HP:0002185) | 2.55529607 |
| 71 | Abnormal eating behavior (HP:0100738) | 2.50518830 |
| 72 | Urinary urgency (HP:0000012) | 2.49525118 |
| 73 | Epileptiform EEG discharges (HP:0011182) | 2.47161547 |
| 74 | Muscle fiber splitting (HP:0003555) | 2.43556858 |
| 75 | Abnormal EKG (HP:0003115) | 2.42717337 |
| 76 | Fetal akinesia sequence (HP:0001989) | 2.42683420 |
| 77 | Abnormality of the lower motor neuron (HP:0002366) | 2.41400964 |
| 78 | Medial flaring of the eyebrow (HP:0010747) | 2.41384992 |
| 79 | Prolonged QT interval (HP:0001657) | 2.40729346 |
| 80 | Lower limb amyotrophy (HP:0007210) | 2.40332774 |
| 81 | Craniofacial dystonia (HP:0012179) | 2.39411465 |
| 82 | Hyperkalemia (HP:0002153) | 2.37078382 |
| 83 | Spastic gait (HP:0002064) | 2.36980727 |
| 84 | Intention tremor (HP:0002080) | 2.35131744 |
| 85 | Absent speech (HP:0001344) | 2.34827428 |
| 86 | Pointed chin (HP:0000307) | 2.33740061 |
| 87 | Round ear (HP:0100830) | 2.33363772 |
| 88 | Impaired vibratory sensation (HP:0002495) | 2.32179756 |
| 89 | Hemiplegia (HP:0002301) | 2.31570107 |
| 90 | Myotonia (HP:0002486) | 2.31300571 |
| 91 | Diplopia (HP:0000651) | 2.31031143 |
| 92 | Abnormality of binocular vision (HP:0011514) | 2.31031143 |
| 93 | Ankyloglossia (HP:0010296) | 2.29673088 |
| 94 | Progressive inability to walk (HP:0002505) | 2.29412765 |
| 95 | Abnormality of the renal cortex (HP:0011035) | 2.29340609 |
| 96 | Resting tremor (HP:0002322) | 2.29308716 |
| 97 | Abnormal finger flexion creases (HP:0006143) | 2.28286326 |
| 98 | Abnormality of ocular smooth pursuit (HP:0000617) | 2.27887957 |
| 99 | Bradykinesia (HP:0002067) | 2.26823275 |
| 100 | EEG with generalized epileptiform discharges (HP:0011198) | 2.26262946 |
| 101 | Dysmetric saccades (HP:0000641) | 2.25843244 |
| 102 | Status epilepticus (HP:0002133) | 2.25004777 |
| 103 | Tubular atrophy (HP:0000092) | 2.22230586 |
| 104 | Gait imbalance (HP:0002141) | 2.20907709 |
| 105 | Chronic hepatic failure (HP:0100626) | 2.19857585 |
| 106 | Polydipsia (HP:0001959) | 2.19100981 |
| 107 | Abnormal drinking behavior (HP:0030082) | 2.19100981 |
| 108 | Papilledema (HP:0001085) | 2.14561106 |
| 109 | Rimmed vacuoles (HP:0003805) | 2.13849465 |
| 110 | Incomplete penetrance (HP:0003829) | 2.12376935 |
| 111 | Lower limb muscle weakness (HP:0007340) | 2.08248827 |
| 112 | Type II lissencephaly (HP:0007260) | 2.04507737 |
| 113 | Blue irides (HP:0000635) | 2.04107171 |
| 114 | Ventricular fibrillation (HP:0001663) | 2.04073682 |
| 115 | Hypsarrhythmia (HP:0002521) | 2.01099481 |
| 116 | Decreased central vision (HP:0007663) | 1.99669905 |
| 117 | Protruding tongue (HP:0010808) | 1.99193578 |
| 118 | Abolished electroretinogram (ERG) (HP:0000550) | 1.99186185 |
| 119 | Sclerocornea (HP:0000647) | 1.98755882 |
| 120 | Polyuria (HP:0000103) | 1.98210139 |
| 121 | Insidious onset (HP:0003587) | 1.97680275 |
| 122 | Termporal pattern (HP:0011008) | 1.97680275 |
| 123 | Inability to walk (HP:0002540) | 1.97278397 |
| 124 | Neuronal loss in central nervous system (HP:0002529) | 1.96954978 |
| 125 | Chronic bronchitis (HP:0004469) | 1.95879219 |
| 126 | Congenital hepatic fibrosis (HP:0002612) | 1.95356056 |
| 127 | Megalencephaly (HP:0001355) | 1.95266112 |
| 128 | Hyporeflexia of lower limbs (HP:0002600) | 1.95099195 |
| 129 | Attenuation of retinal blood vessels (HP:0007843) | 1.94372712 |
| 130 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 1.93884144 |
| 131 | Limb dystonia (HP:0002451) | 1.93733428 |
| 132 | Syncope (HP:0001279) | 1.92159168 |
| 133 | EMG: myopathic abnormalities (HP:0003458) | 1.91179711 |
| 134 | Congenital primary aphakia (HP:0007707) | 1.90851179 |
| 135 | Abnormality of the corticospinal tract (HP:0002492) | 1.89076137 |
| 136 | Abnormality of salivation (HP:0100755) | 1.87244352 |
| 137 | Decreased circulating renin level (HP:0003351) | 1.86981642 |
| 138 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 1.84159588 |
| 139 | Hip contracture (HP:0003273) | 1.82979215 |
| 140 | Difficulty running (HP:0009046) | 1.81989128 |
| 141 | Generalized myoclonic seizures (HP:0002123) | 1.81267245 |
| 142 | Areflexia of lower limbs (HP:0002522) | 1.81183388 |
| 143 | Aqueductal stenosis (HP:0002410) | 1.79379932 |
| 144 | Bronchiectasis (HP:0002110) | 1.79300833 |
| 145 | Anencephaly (HP:0002323) | 1.78834012 |
| 146 | Gait ataxia (HP:0002066) | 1.77600406 |
| 147 | Ulnar deviation of the wrist (HP:0003049) | 1.77255409 |
| 148 | Clonus (HP:0002169) | 1.76446427 |
| 149 | Nephrogenic diabetes insipidus (HP:0009806) | 1.76425491 |
| 150 | Bundle branch block (HP:0011710) | 1.75817685 |
| 151 | Increased corneal curvature (HP:0100692) | 1.75401701 |
| 152 | Keratoconus (HP:0000563) | 1.75401701 |
| 153 | Optic nerve hypoplasia (HP:0000609) | 1.74874963 |
| 154 | Neoplasm of the heart (HP:0100544) | 1.74702824 |
| 155 | Genital tract atresia (HP:0001827) | 1.74689514 |
| 156 | Deeply set eye (HP:0000490) | 1.74199968 |
| 157 | Autism (HP:0000717) | 1.74198309 |
| 158 | Truncus arteriosus (HP:0001660) | 1.74011672 |
| 159 | Generalized hypopigmentation of hair (HP:0011358) | 1.73787094 |
| 160 | Male pseudohermaphroditism (HP:0000037) | 1.73340550 |
| 161 | Primary atrial arrhythmia (HP:0001692) | 1.73154562 |
| 162 | Insomnia (HP:0100785) | 1.72962279 |
| 163 | Myopathic facies (HP:0002058) | 1.72626084 |
| 164 | Psychosis (HP:0000709) | 1.72350026 |
| 165 | Frequent falls (HP:0002359) | 1.72210485 |
| 166 | Furrowed tongue (HP:0000221) | 1.71945060 |
| 167 | Postaxial foot polydactyly (HP:0001830) | 1.71053440 |
| 168 | Fair hair (HP:0002286) | 1.70560688 |
| 169 | Abnormality of oral frenula (HP:0000190) | 1.70451203 |
| 170 | Malignant hyperthermia (HP:0002047) | 1.69197230 |
| 171 | Inappropriate behavior (HP:0000719) | 1.69126056 |
| 172 | Central scotoma (HP:0000603) | 1.68530402 |
| 173 | Bowel incontinence (HP:0002607) | 1.67961694 |
| 174 | Occipital encephalocele (HP:0002085) | 1.67619158 |
| 175 | Abnormal rod and cone electroretinograms (HP:0008323) | 1.66470759 |
| 176 | Vaginal atresia (HP:0000148) | 1.66241194 |
| 177 | Neck muscle weakness (HP:0000467) | 1.64803968 |
| 178 | Left ventricular hypertrophy (HP:0001712) | 1.63653455 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EPHA4 | 6.42876759 |
| 2 | NTRK3 | 5.08757839 |
| 3 | OBSCN | 5.03179069 |
| 4 | FRK | 4.33859924 |
| 5 | MAP3K9 | 3.17539343 |
| 6 | RIPK4 | 3.03927725 |
| 7 | MAP3K4 | 2.53334559 |
| 8 | MINK1 | 2.49541117 |
| 9 | GRK1 | 2.38000188 |
| 10 | MARK1 | 2.37679599 |
| 11 | NTRK2 | 2.25127094 |
| 12 | KSR1 | 2.24965941 |
| 13 | NTRK1 | 2.23849381 |
| 14 | TNIK | 2.23446958 |
| 15 | ADRBK2 | 2.05981849 |
| 16 | KSR2 | 2.05826648 |
| 17 | DAPK2 | 2.05759087 |
| 18 | MAP2K7 | 1.97150884 |
| 19 | INSRR | 1.93501045 |
| 20 | BMPR1B | 1.87629429 |
| 21 | WNK3 | 1.85467433 |
| 22 | PAK6 | 1.84531418 |
| 23 | PRKD3 | 1.79895582 |
| 24 | MAP4K2 | 1.67228337 |
| 25 | CAMKK1 | 1.67129132 |
| 26 | SIK2 | 1.63517560 |
| 27 | CASK | 1.58195636 |
| 28 | FES | 1.57695521 |
| 29 | CDK5 | 1.54218016 |
| 30 | MAP3K13 | 1.49576645 |
| 31 | DAPK1 | 1.49080527 |
| 32 | PRPF4B | 1.47342201 |
| 33 | MAPK15 | 1.47210540 |
| 34 | MAP2K4 | 1.41791991 |
| 35 | STK38 | 1.38213338 |
| 36 | PNCK | 1.29405030 |
| 37 | BMPR2 | 1.28039729 |
| 38 | STK39 | 1.24312721 |
| 39 | MAPK13 | 1.19540180 |
| 40 | ARAF | 1.18052642 |
| 41 | PIK3CG | 1.17564291 |
| 42 | PRKCG | 1.15271960 |
| 43 | CAMK2A | 1.12067374 |
| 44 | TAOK3 | 1.11078346 |
| 45 | MAP3K12 | 1.10652103 |
| 46 | PLK2 | 1.10092082 |
| 47 | WNK4 | 1.09271798 |
| 48 | TIE1 | 1.08201905 |
| 49 | PKN1 | 1.07645409 |
| 50 | CCNB1 | 1.07389058 |
| 51 | MUSK | 1.05968174 |
| 52 | CAMK2B | 1.05742906 |
| 53 | PTK2B | 1.04500821 |
| 54 | RAF1 | 1.01932432 |
| 55 | TYRO3 | 1.00749375 |
| 56 | GRK5 | 0.98541282 |
| 57 | CAMKK2 | 0.93159874 |
| 58 | ACVR1B | 0.91987088 |
| 59 | NUAK1 | 0.90991786 |
| 60 | SGK223 | 0.88994930 |
| 61 | SGK494 | 0.88994930 |
| 62 | SIK3 | 0.87950840 |
| 63 | SGK1 | 0.87100623 |
| 64 | TNK2 | 0.86003590 |
| 65 | CAMK1 | 0.85662009 |
| 66 | MAP3K2 | 0.85419882 |
| 67 | SGK2 | 0.85365054 |
| 68 | ZAK | 0.83111700 |
| 69 | TAOK1 | 0.82917668 |
| 70 | CDK18 | 0.81016907 |
| 71 | STK11 | 0.76403555 |
| 72 | CDK15 | 0.76038116 |
| 73 | DMPK | 0.74333812 |
| 74 | NEK6 | 0.74150740 |
| 75 | MARK2 | 0.72428057 |
| 76 | PRKCH | 0.72205209 |
| 77 | PINK1 | 0.72177068 |
| 78 | CDK14 | 0.71031934 |
| 79 | UHMK1 | 0.70846141 |
| 80 | ADRBK1 | 0.70645544 |
| 81 | TTN | 0.70150402 |
| 82 | MAPK12 | 0.69602490 |
| 83 | SGK3 | 0.68246663 |
| 84 | DYRK2 | 0.67924514 |
| 85 | MAPKAPK3 | 0.67163905 |
| 86 | MAPKAPK5 | 0.66410135 |
| 87 | FGFR2 | 0.65146309 |
| 88 | CDK11A | 0.65008695 |
| 89 | PIK3CA | 0.64973195 |
| 90 | DYRK1A | 0.64895691 |
| 91 | NME1 | 0.64873790 |
| 92 | FGR | 0.64305713 |
| 93 | CSNK1G1 | 0.63708926 |
| 94 | MKNK2 | 0.63510750 |
| 95 | CAMK2D | 0.62890205 |
| 96 | BCR | 0.61910687 |
| 97 | PRKG1 | 0.61630974 |
| 98 | STK38L | 0.61541583 |
| 99 | PHKG2 | 0.61356785 |
| 100 | PHKG1 | 0.61356785 |
| 101 | ERBB3 | 0.61249074 |
| 102 | MAP3K7 | 0.60304041 |
| 103 | RET | 0.57430409 |
| 104 | CDC42BPA | 0.57099708 |
| 105 | PRKAA1 | 0.56277725 |
| 106 | RPS6KA3 | 0.55178304 |
| 107 | PAK3 | 0.54980037 |
| 108 | PDPK1 | 0.54912303 |
| 109 | PRKCZ | 0.54820218 |
| 110 | MAPK10 | 0.54553725 |
| 111 | FYN | 0.53853227 |
| 112 | LMTK2 | 0.53811279 |
| 113 | PDK1 | 0.53429320 |
| 114 | PRKCE | 0.52447945 |
| 115 | CAMK1G | 0.52213203 |
| 116 | TGFBR1 | 0.51418536 |
| 117 | ROCK1 | 0.49221086 |
| 118 | PRKAA2 | 0.48073283 |
| 119 | CDK19 | 0.47457592 |
| 120 | TLK1 | 0.46479288 |
| 121 | WNK1 | 0.46131954 |
| 122 | MAP3K1 | 0.45217722 |
| 123 | CSNK1G3 | 0.43214486 |
| 124 | CAMK2G | 0.42911190 |
| 125 | FER | 0.41062185 |
| 126 | AKT3 | 0.40783218 |
| 127 | CSNK1A1 | 0.40571774 |
| 128 | ALK | 0.39847663 |
| 129 | PRKACB | 0.39730300 |
| 130 | PRKCB | 0.38796415 |
| 131 | CSNK1D | 0.38117509 |
| 132 | MAP2K1 | 0.37531421 |
| 133 | ROCK2 | 0.36963745 |
| 134 | OXSR1 | 0.36525250 |
| 135 | PRKD2 | 0.36060496 |
| 136 | CSNK1A1L | 0.35474067 |
| 137 | PRKACA | 0.34920593 |
| 138 | CSNK1G2 | 0.34561754 |
| 139 | LATS2 | 0.34487215 |
| 140 | TRPM7 | 0.34134181 |
| 141 | MAP2K6 | 0.33950998 |
| 142 | TRIM28 | 0.33686452 |
| 143 | PRKCA | 0.32854857 |
| 144 | ERBB2 | 0.32809795 |
| 145 | CAMK4 | 0.31690830 |
| 146 | PRKCQ | 0.28970111 |
| 147 | CSNK1E | 0.28242244 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nicotine addiction_Homo sapiens_hsa05033 | 4.12131160 |
| 2 | Olfactory transduction_Homo sapiens_hsa04740 | 2.93755046 |
| 3 | Morphine addiction_Homo sapiens_hsa05032 | 2.85207252 |
| 4 | * Circadian entrainment_Homo sapiens_hsa04713 | 2.82297168 |
| 5 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.82000886 |
| 6 | GABAergic synapse_Homo sapiens_hsa04727 | 2.81424796 |
| 7 | Long-term potentiation_Homo sapiens_hsa04720 | 2.81200528 |
| 8 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.73568434 |
| 9 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.68387067 |
| 10 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.63814400 |
| 11 | Dopaminergic synapse_Homo sapiens_hsa04728 | 2.28405589 |
| 12 | * Salivary secretion_Homo sapiens_hsa04970 | 2.19347920 |
| 13 | Cholinergic synapse_Homo sapiens_hsa04725 | 2.00880324 |
| 14 | Cocaine addiction_Homo sapiens_hsa05030 | 2.00455783 |
| 15 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.97302751 |
| 16 | Renin secretion_Homo sapiens_hsa04924 | 1.94291055 |
| 17 | Insulin secretion_Homo sapiens_hsa04911 | 1.93180726 |
| 18 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.88834714 |
| 19 | Taste transduction_Homo sapiens_hsa04742 | 1.87362390 |
| 20 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.83137408 |
| 21 | * Calcium signaling pathway_Homo sapiens_hsa04020 | 1.83039396 |
| 22 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.77489795 |
| 23 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.77429679 |
| 24 | * Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.72157250 |
| 25 | Long-term depression_Homo sapiens_hsa04730 | 1.70601450 |
| 26 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.67364538 |
| 27 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.62895956 |
| 28 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.53817393 |
| 29 | Histidine metabolism_Homo sapiens_hsa00340 | 1.51685326 |
| 30 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.51185454 |
| 31 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.45671896 |
| 32 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.41325892 |
| 33 | Gap junction_Homo sapiens_hsa04540 | 1.40054333 |
| 34 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.39786182 |
| 35 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.22744552 |
| 36 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.22345830 |
| 37 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.21642277 |
| 38 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.21399844 |
| 39 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.20597221 |
| 40 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.19682356 |
| 41 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.18543535 |
| 42 | Axon guidance_Homo sapiens_hsa04360 | 1.17805352 |
| 43 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.16827908 |
| 44 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.13652096 |
| 45 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.11187013 |
| 46 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.08549817 |
| 47 | Glioma_Homo sapiens_hsa05214 | 1.08105625 |
| 48 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.07225244 |
| 49 | Phototransduction_Homo sapiens_hsa04744 | 1.06717031 |
| 50 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.06669093 |
| 51 | Melanogenesis_Homo sapiens_hsa04916 | 1.05466581 |
| 52 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.04584976 |
| 53 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.03233524 |
| 54 | ABC transporters_Homo sapiens_hsa02010 | 1.03021973 |
| 55 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.02723999 |
| 56 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.01551829 |
| 57 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.00827541 |
| 58 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.98685073 |
| 59 | Parkinsons disease_Homo sapiens_hsa05012 | 0.98533626 |
| 60 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.97927610 |
| 61 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.97578773 |
| 62 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.97561875 |
| 63 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.96711046 |
| 64 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.95886293 |
| 65 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.95607586 |
| 66 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.95235835 |
| 67 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.95168426 |
| 68 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.92492376 |
| 69 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.90711123 |
| 70 | Alzheimers disease_Homo sapiens_hsa05010 | 0.85826680 |
| 71 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.83492314 |
| 72 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.83401356 |
| 73 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.81471766 |
| 74 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.79916177 |
| 75 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.79885813 |
| 76 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.79261686 |
| 77 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.78727270 |
| 78 | Huntingtons disease_Homo sapiens_hsa05016 | 0.77585661 |
| 79 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.77078863 |
| 80 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.76627786 |
| 81 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.75438576 |
| 82 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.75144257 |
| 83 | Peroxisome_Homo sapiens_hsa04146 | 0.72357303 |
| 84 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.71596593 |
| 85 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.67066668 |
| 86 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.66134191 |
| 87 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.66089896 |
| 88 | Retinol metabolism_Homo sapiens_hsa00830 | 0.65059852 |
| 89 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.64634856 |
| 90 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.64520856 |
| 91 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.64400552 |
| 92 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.62957689 |
| 93 | Circadian rhythm_Homo sapiens_hsa04710 | 0.62759682 |
| 94 | Alcoholism_Homo sapiens_hsa05034 | 0.60631163 |
| 95 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.59072142 |
| 96 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.57732657 |
| 97 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.57237829 |
| 98 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.56556149 |
| 99 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.56493187 |
| 100 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.56223299 |
| 101 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.55993172 |
| 102 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.55301945 |
| 103 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.53496290 |
| 104 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.52784997 |
| 105 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.51886314 |
| 106 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.51313365 |
| 107 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.51161694 |
| 108 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.50703266 |
| 109 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.50250937 |
| 110 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.48725254 |
| 111 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.48689345 |
| 112 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.48470446 |
| 113 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.48075801 |
| 114 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.46466535 |
| 115 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.45459025 |
| 116 | Bile secretion_Homo sapiens_hsa04976 | 0.45334646 |
| 117 | Tight junction_Homo sapiens_hsa04530 | 0.44110513 |
| 118 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.43900415 |
| 119 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.43568310 |
| 120 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.42992736 |
| 121 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.42827859 |
| 122 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.42489967 |
| 123 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.42314963 |
| 124 | Basal transcription factors_Homo sapiens_hsa03022 | 0.39779216 |
| 125 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.36747139 |
| 126 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.36566177 |
| 127 | Purine metabolism_Homo sapiens_hsa00230 | 0.35638624 |
| 128 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.33193690 |
| 129 | Endocytosis_Homo sapiens_hsa04144 | 0.31633959 |
| 130 | Prion diseases_Homo sapiens_hsa05020 | 0.31562999 |
| 131 | Endometrial cancer_Homo sapiens_hsa05213 | 0.29610402 |
| 132 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.29524863 |
| 133 | Mineral absorption_Homo sapiens_hsa04978 | 0.29264063 |
| 134 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.29069181 |
| 135 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.28865624 |
| 136 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.27553504 |
| 137 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.26943853 |
| 138 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.25767262 |
| 139 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.25755081 |
| 140 | Platelet activation_Homo sapiens_hsa04611 | 0.25133869 |

